Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: ChemoCentryx pulls conditional approval filing to rejig regulatory plan .ChemoCentryx has pulled a filing for conditional approval of its treatment for active anti-neutrophil cytoplasmic antibody-associated vasculitis. The biotech … Continue reading